Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

14/05/2021 08:00

May 14 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2021        Mar 31, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              655 mln             123 mln           2.74     
                  (+430.7 pct)         (-64.5 pct)     (+147.3 pct) 
  Operating          149 mln          loss 273 mln        420 mln   
  Recurring          268 mln          loss 267 mln        427 mln   
  Net                188 mln          loss 328 mln        343 mln   
  EPS               9.00 yen         loss 15.66 yen      16.41 yen  
  EPS Diluted       9.00 yen                                        
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T